coronavirus

Federal Government Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine

WASHINGTON, D.C. — The Biden Administration announced it recently secured 10 million treatment courses of Pfizer’s promising COVID-19 oral antiviral drug, contingent on emergency use authorization (EUA) or approval from …

Federal Government Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine Read More

Immunome

Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing

EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against the SARS-CoV-2 Delta variant in pre-clinical pseudovirus testing. Furthermore, IMM-BCP-01 showed …

Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing Read More